As we’ve discussed previously, Nestlé Health (a subsidiary of Nestlé) recently introduced a new product containing Nicotinamide Riboside “NR” (FAQs) (Reviews) in partnership with Chromadex. Since then, Nestlé has launched a vigorous campaign to educate the general public about N.A.D. and NR in an effort to accelerate consumer adoption of its various new Celltrient products. At RaisingNAD, we’re always on the lookout for content that explains NAD and NR in plain, non-scientific English — even if it comes from an advertisement. So, here’s some key quotes from a Nestlé “Sponsored Article” in Newsweek:
Category: PRESS
We know that Hong Kong billionaire Li Ka-Shing is a savvy investor. He’s reportedly made $10B+ on an early investment in ZOOM (ticker: ZM). But does he use ZOOM? We don’t know. What about his investment in small-cap Chromadex? Does he personally take their supplement Nicotinamide Riboside “NR” (FAQs) (Reviews)?
This week’s New York Times Magazine suggests that “many Covid-19 patients may be dying from their immune response to the virus, NOT from the virus itself.” COVID-19 patients’ immune overreaction is known as a “Cytokine Storm”. What’s the NAD connection? Harvard’s David Sinclair and City of Hope’s Charles Brenner agree — “cytokine storms” are the result of depleted NAD. And thus it’s plausible that NAD boosters could help.
It’s often useful to see how health products and their benefits are described in mainstream media. In this case, Paris Vogue and the UK’s HELLO! magazine recently wrote about the growing trend behind NAD supplementation.
Nutraceuticals World reports on a new study indicating that “in liver samples of patients with alcohol-related liver disease, lowered liver function correlated with a decline in NAD levels”. The article also points out that NAD levels have been shown to increase through supplementation with Nicotinamide Riboside “NR” (FAQs) (Reviews). Full article HERE.